Rates of psoriasis in patients with palmoplantar pustulosis
- PMID: 31399995
- DOI: 10.1111/bjd.18314
Rates of psoriasis in patients with palmoplantar pustulosis
Comment on
-
Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.Br J Dermatol. 2019 Nov;181(5):976-982. doi: 10.1111/bjd.17832. Epub 2019 Jun 2. Br J Dermatol. 2019. PMID: 30815849
References
-
- Pink AE, Smith CH. Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists. Br J Dermatol 2017; 177:7-8.
-
- Poelman SM, Keeling CP, Metelitsa AI. Practical guidelines for managing patients with psoriasis on biologics: an update. J Cutan Med Surg 2019; 23 (Suppl. 1):3S-12S.
-
- Mrowietz U, Bachelez H, Burden AD et al. Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: results of the 2PRECISE study. J Am Acad Dermatol 2019; 80:1344-52.
-
- Liang Y, Xing X, Beamer MA et al. Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders. J Allergy Clin Immunol 2017; 139:1217-27.
-
- Andersen YMF, Augustin M, Petersen J et al. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis. Br J Dermatol 2019; 181:976-82.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
